ALEXANDRIA SCHWAB: Open Payments
NPI 1194295477 · BAY CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,339 in 122 payments from 27 companies in 2025. Trend: 2023 $2,399 · 2024 $2,121 · 2025 $2,339
Food & beverage: $2,339
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $381 |
| Lilly USA, LLC | 15 | $256 |
| AstraZeneca Pharmaceuticals LP | 5 | $197 |
| Novo Nordisk Inc | 9 | $176 |
| Vanda Pharmaceuticals Inc. | 7 | $160 |
| GlaxoSmithKline, LLC. | 20 | $145 |
| Astellas Pharma US Inc | 4 | $107 |
| Dexcom, Inc. | 2 | $93 |
| Abbott Laboratories | 4 | $89 |
| PFIZER INC. | 5 | $87 |
Products named: QULIPTA, MOUNJARO, FANAPT, BREZTRI, TRELEGY ELLIPTA, Wegovy, Veozah, Dexcom G6 Transmitter.
Industry payments across MI — which companies pay providers there.
